Stock ALGS ALIGOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Aligos Therapeutics, Inc.

Equities

ALGS

US01626L1052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
0.659 USD +3.21% Intraday chart for Aligos Therapeutics, Inc. -2.96% -0.75%
Apr. 03 Aligos Therapeutics, Inc. Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects CI
Mar. 27 Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies CI
096be9cec.yOiXfLnwtncdDz0je_UXFaIM5SskzujXCGSPIxC1pp0.8NHTDOGV_A1bN1ROS7knLe85s0ZurLqFey3LEkj51du_ntkOwafUPV49Ug~43ea66669d8d9430e52c1bf328f6dc93
  1. Stock Market
  2. Equities
  3. ALGS Stock
  4. Charts Aligos Therapeutics, Inc.
  5. News Chart